[1]
Gomez-Cobos , V., Medina , E., Ribadeneira-Espinoza, M., Romero-Cortez , F. and Romero-Proaño, P. 2023. Quality of life and adherence to treatment in patients with benign prostatic hyperplasia treated with tamsulosin 0.4 mg/dutasteride 0.5 mg for 12 weeks. Revista de la Facultad de Ciencias Médicas (Quito). 48, 2 (Dec. 2023), 36–46. DOI:https://doi.org/10.29166/rfcmq.v48i2.4435.